-
201
MiRNAs as major players in brain health and disease: current knowledge and future perspectives
Published 2025-01-01“…Several reports show downregulation of miR-135 in glioblastoma, indicating its tumor suppressor role in the pathogenesis of brain tumors. …”
Get full text
Article -
202
In vivo MRS study of long-term effects of traumatic intracranial injection of a culture medium in mice
Published 2023-11-01“…Orthotopic transplantation of glioblastoma cells in the brain of laboratory mice is a common animal model for studying brain tumors. …”
Get full text
Article -
203
Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells
Published 2015-08-01“…We also show that patient-derived glioblastoma cells with low proteasome activity have higher frequency of tumor formation in mouse xenografts. …”
Get full text
Article -
204
Spectroscopically Well-Characterized RGD Optical Probe as a Prerequisite for Lifetime-Gated Tumor Imaging
Published 2011-11-01“…For in vivo imaging, human glioblastoma cells were subcutaneously implanted into nude mice, and in vivo fluorescence intensity and lifetime were measured. …”
Get full text
Article -
205
Research progress on platelets in glioma
Published 2025-01-01“…Gliomas are the most common primary neuroepithelial tumors of the central nervous system in adults, of which glioblastoma is the deadliest subtype. Apart from the intrinsically indestructible characteristics of glioma (stem) cells, accumulating evidence suggests that the tumor microenvironment also plays a vital role in the refractoriness of glioblastoma. …”
Get full text
Article -
206
Global research landscape and hotspots for ferroptosis in glioma: A comprehensive bibliometric and visual analysis
Published 2025-02-01“…While recent research has explored the link between ferroptosis and glioblastoma, there is a lack of comprehensive bibliometric analyses specifically addressing this relationship and its connection to glioblastoma. …”
Get full text
Article -
207
Nanoparticle-in-Hydrogel Delivery System for the Sequential Release of Two Drugs
Published 2025-01-01“…Background/Objectives: Glioblastoma is the most common and lethal primary brain tumor. …”
Get full text
Article -
208
Pan-cancer analysis of SOX2: Prognostic implications and potential as a therapeutic target in immune checkpoint modulation
Published 2025-02-01“…Significant downregulation of SOX2 expression was observed in colorectal adenocarcinoma, esophageal carcinoma, rectum adenocarcinoma, stomach adenocarcinoma, and testicular germ cell tumors, whereas its expression was upregulated in cervical squamous cell carcinoma, glioblastoma multiforme, lower grade glioma, lung adenocarcinoma, and lung squamous cell carcinoma.Survival analysis showed that low SOX2 expression correlated with better prognosis in bladder cancer, liver hepatocellular carcinoma, kidney renal clear cell carcinoma, and sarcoma, whereas high SOX2 expression was associated with poor prognosis in lung adenocarcinoma, and lung squamous cell carcinoma, glioblastoma multiforme, lower grade glioma. …”
Get full text
Article -
209
Hybrid models of cell and tissue dynamics in tumor growth
Published 2015-07-01“…We review aspects of the general approachand discuss applications to breast cancer and glioblastoma.…”
Get full text
Article -
210
Single-cell sequencing uncovers the mechanistic role of DAPK1 in glioma and its diagnostic and prognostic implications
Published 2025-01-01“…DAPK1, serving as a marker gene for the terminal subpopulation, exhibited an association with poor prognosis.ConclusionsDAPK1-based prognostic models show promise for accurately predicting outcomes in glioblastoma and glioma. An in-depth examination of DAPK1’s specific mechanisms in glioblastoma could elucidate its role in immunotherapy response. …”
Get full text
Article -
211
Radiocobalt-Labeling of a Polypyridylamine Chelate Conjugated to GE11 for EGFR-Targeted Theranostics
Published 2025-01-01“…The overexpression of the epidermal growth factor receptor (EGFR) in certain types of prostate cancers and glioblastoma makes it a promising target for targeted radioligand therapy. …”
Get full text
Article -
212
Overexpression of DcR3 and Its Significance on Tumor Cell Differentiation and Proliferation in Glioma
Published 2014-01-01“…Meanwhile, the expression of DcR3 protein was also measured in the supernatants of 8 glioma cell lines and glioma cells freshly prepared from 8 human glioblastoma specimens by using western blot. Results. …”
Get full text
Article -
213
Bioactivity and metabolic profiling of crude extracts from endophytic bacteria linked to Solanum mauritianum scope: Discovery of antibacterial and anticancer properties
Published 2025-01-01“…The cytotoxicity assays on UMG87 glioblastoma and A549 lung carcinoma cells revealed that the secondary metabolites did not induce cell death but instead promoted cell proliferation with different viability rates. …”
Get full text
Article -
214
V-ATPase in glioma stem cells: a novel metabolic vulnerability
Published 2025-01-01“…Abstract Background Glioblastoma (GBM) is a lethal brain tumor characterized by the glioma stem cell (GSC) niche. …”
Get full text
Article -
215
Rethinking Brain Cancer Therapy: Tumor Enzyme Activatable Theranostic Nanoparticles
Published 2017-09-01“…Data showed that the TNPs caused selective toxic effects in MMP-14-expressing glioblastoma and not normal brain. In addition, the iron oxide nanoparticle backbone enabled in vivo drug tracking with magnetic resonance imaging (MRI). …”
Get full text
Article -
216
Identification of Molecular Signatures in Neural Differentiation and Neurological Diseases Using Digital Color-Coded Molecular Barcoding
Published 2020-01-01“…We will also describe relevant examples of the use of this technique for the characterization of the heterogeneous composition of the brain tumor glioblastoma multiforme.…”
Get full text
Article -
217
Impact of re-operation on progression-free survival in patients with recurrent GBM: Experience in a tertiary referral center.
Published 2025-01-01“…<h4>Background</h4>Reoperation for patients with recurrent glioblastoma multiforme (GBM) is a highly debated topic within the medical community. …”
Get full text
Article -
218
Earlier Diagnosis of Progressive Disease during Bevacizumab Treatment Using O-(2-F-Fluorethyl)-L-Tyrosine Positron Emission Tomography in Comparison with Magnetic Resonance Imaging
Published 2013-07-01“…We present 18 F-FET-PET imaging findings in a glioblastoma patient during bevacizumab treatment suggesting an earlier diagnosis of tumor progression than magnetic resonance imaging changes, which are based on the RANO criteria.…”
Get full text
Article -
219
The Effect of the Concurrent Use of Angiotensin-Converting Enzyme Inhibitors or Receptor Blockers on Toxicity and Outcomes in Patients Treated with Radiotherapy: A Systematic Revie...
Published 2025-01-01“…ACEI/ARB users showed reduced symptomatic radiation necrosis in brain metastases and better 6-month functional independence in supratentorial glioblastoma. Among six studies reporting survival, ACEI/ARB users had longer median survival in early-stage non-small-cell lung cancer and glioblastoma but shorter survival in small cell lung cancer and brain metastases. …”
Get full text
Article -
220
Expression of LGI1 Impairs Proliferation and Survival of HeLa Cells
Published 2009-01-01“…The LGI1 gene was suggested to function as tumor suppressor for its ability to reduce malignant features of glioblastoma cells. In support to this proposal were the findings that overexpression of LGI1 in neuroblastoma cells inhibited proliferation and induced apoptosis. …”
Get full text
Article